Recently Kamiya et al. developed an approach to generate NK cells lacking NKG2A expression by transduction of NKG2A protein expression blockers resulting in increased cytotoxicity towards HLA-E expressing tumor cells [122]. The gene discussed is KLRC1; the disease is neoplasm.